The association between cannabis use and depression: a systematic review and meta-analysis of longitudinal studies S Lev-Ran, M Roerecke, B Le Foll, TP George, K McKenzie, J Rehm Psychological medicine 44 (4), 797-810, 2014 | 623 | 2014 |
Lower-risk cannabis use guidelines: a comprehensive update of evidence and recommendations B Fischer, C Russell, P Sabioni, W Van Den Brink, B Le Foll, W Hall, ... American journal of public health 107 (8), e1-e12, 2017 | 465 | 2017 |
Genetics of dopamine receptors and drug addiction: a comprehensive review B Le Foll, A Gallo, Y Le Strat, L Lu, P Gorwood Behavioural pharmacology 20 (1), 1-17, 2009 | 459 | 2009 |
The dopamine D3 receptor: a therapeutic target for the treatment of neuropsychiatric disorders P Sokoloff, J Diaz, BL Foll, O Guillin, L Leriche, E Bezard, C Gross CNS & Neurological Disorders-Drug Targets (Formerly Current Drug Targets-CNS …, 2006 | 418 | 2006 |
Dopamine D3 receptors expressed by all mesencephalic dopamine neurons J Diaz, C Pilon, B Le Foll, C Gros, A Triller, JC Schwartz, P Sokoloff Journal of Neuroscience 20 (23), 8677-8684, 2000 | 400 | 2000 |
Psychosocial interventions for cannabis use disorder PJ Gates, P Sabioni, J Copeland, B Le Foll, L Gowing Cochrane database of systematic reviews, 2016 | 363 | 2016 |
Cannabinoid CB1 receptor antagonists as promising new medications for drug dependence B Le Foll, SR Goldberg Journal of Pharmacology and Experimental Therapeutics 312 (3), 875-883, 2005 | 346 | 2005 |
Prevalence and correlates of major depressive episode in pregnant and postpartum women in the United States Y Le Strat, C Dubertret, B Le Foll Journal of affective disorders 135 (1-3), 128-138, 2011 | 345 | 2011 |
Cannabis use and cannabis use disorder JP Connor, D Stjepanović, B Le Foll, E Hoch, AJ Budney, WD Hall Nature Reviews Disease Primers 7 (1), 16, 2021 | 308 | 2021 |
Identification of dopamine D1–D3 receptor heteromers: indications for a role of synergistic D1–D3 receptor interactions in the striatum D Marcellino, S Ferré, V Casadó, A Cortés, B Le Foll, C Mazzola, F Drago, ... Journal of Biological Chemistry 283 (38), 26016-26025, 2008 | 283 | 2008 |
Opioid-sparing effect of cannabinoids: a systematic review and meta-analysis S Nielsen, P Sabioni, JM Trigo, MA Ware, BD Betz-Stablein, B Murnion, ... Neuropsychopharmacology 42 (9), 1752-1765, 2017 | 278 | 2017 |
Nicotine induces conditioned place preferences over a large range of doses in rats B Le Foll, SR Goldberg Psychopharmacology 178, 481-492, 2005 | 273 | 2005 |
A transdiagnostic dimensional approach towards a neuropsychological assessment for addiction: an international Delphi consensus study M Yücel, E Oldenhof, SH Ahmed, D Belin, J Billieux, H Bowden‐Jones, ... Addiction 114 (6), 1095-1109, 2019 | 245 | 2019 |
The dopamine D3 receptor, a quarter century later P Sokoloff, B Le Foll European Journal of Neuroscience 45 (1), 2-19, 2017 | 228 | 2017 |
Child marriage in the United States and its association with mental health in women Y Le Strat, C Dubertret, B Le Foll Pediatrics 128 (3), 524-530, 2011 | 218 | 2011 |
Rimonabant, a CB1 antagonist, blocks nicotine-conditioned place preferences B Le Foll, SR Goldberg Neuroreport 15 (13), 2139-2143, 2004 | 212 | 2004 |
The dopamine D3 receptor and drug dependence: effects on reward or beyond? B Le Foll, SR Goldberg, P Sokoloff Neuropharmacology 49 (4), 525-541, 2005 | 211 | 2005 |
Effects of nicotine in experimental animals and humans: an update on addictive properties BL Foll, SR Goldberg Nicotine Psychopharmacology, 335-367, 2009 | 209 | 2009 |
A single cocaine exposure increases BDNF and D3 receptor expression: implications for drug-conditioning B Le Foll, J Diaz, P Sokoloff Neuroreport 16 (2), 175-178, 2005 | 208 | 2005 |
Role of the dopamine D3 receptor in reactivity to cocaine‐associated cues in mice B Le Foll, H Francès, J Diaz, JC Schwartz, P Sokoloff European Journal of Neuroscience 15 (12), 2016-2026, 2002 | 208 | 2002 |